Replay available

Trevi Therapeutics, Inc. (TRVI) Q2 2026 Earnings Call

Trevi Therapeutics, Inc. (NASDAQ: TRVI) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.

Thu, August 6, 2026 at 4:30 PMendedReplay
Trevi Therapeutics, Inc. (TRVI) Q2 2026 Earnings Call

Hosted by

Featured presenters

Jennifer Good

President and CEO

David Hastings

Chief Financial Officer

Rowana Ruiz

Analyst, Leerink Partners

Dr. James Cassella

Chief Development Officer

Farrell Simon

Chief Commercial Officer

Annabelle Samimi

Analyst, Stiefel

Judah Frommer

Analyst, Morgan Stanley

William Wood

Analyst, B. Riley Securities

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Trevi Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.212 Good afternoon and welcome to the Trevi Therapeutics second quarter 2026 earnings conference 00:00:05.212 -- 00:00:09.213 call. At this time, all participants are in a listen-only mode. 00:00:09.213 -- 00:00:13.434 After today's presentation, there will be an opportunity to ask questions. 00:00:13.434 -- 00:00:18.475 To ask a question during the session, you will need to press star 1 1 on your telephone. 00:00:18.475 -- 00:00:22.236 You will then hear an automated message advising that your hand is raised. 00:00:22.236 -- 00:00:26.237 To withdraw your question, please press star 1 1 again. 00:00:26.237 -- 00:00:29.700 Please be advised that today's conference is being recorded. 00:00:29.700 -- 00:00:33.243 Various remarks that management makes during this conference call about the company's 00:00:33.243 -- 00:00:38.407 future expectations, plans, and prospects can constitute forward-looking statements for 00:00:38.407 -- 00:00:43.031 purposes of the safe harbor provisions under the Private Securities Litigation Reform 00:00:43.031 -- 00:00:44.712 Act of 95. 00:00:44.712 -- 00:00:49.396 Actual results may differ materially from those indicated by these forward-looking statements 00:00:49.396 -- 00:00:54.060 as a result of various important factors, including those discussed in the risk factors 00:00:54.060 -- 00:00:59.004 section of the company's most recent annual report form 10K, which the company filed 00:00:59.004 -- 00:01:04.145 with the SEC on March 17th, 2026, as updated by our subsequent 00:01:04.145 -- 00:01:06.506 filings with the SEC. 00:01:06.506 -- 00:01:10.328 In addition, any forward-looking statements represents the company's views only as of 00:01:10.328 -- 00:01:15.429 today and should not be relied upon as represe...